beta

ACHV

Achieve Life Sciences Inc.

Achv

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Achieve Life Sciences Inc is a specialty pharmaceutical company. The company is developing cytisine as a smoking cessation aid. The cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor.

Market Cap: 22.6 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.achievelifesciences.com

Shares Outstanding: 11.9 Million

Float: 9.35 Million

Dividend: 0.0 (0.0%)

Beta: 2.271952

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 189 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1411 trading days

From: 2014-03-10 To: 2019-10-11

Lowest Point:

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...

Achieve Life Sciences up 16% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-06-11 04:13:28:000

Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...

Achieve Life Sciences up 16% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-06-11 04:13:28:000

Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...

Achieve Life Sciences up 16% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-06-11 04:13:28:000

Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

via: PR Newswire at 2019-06-11 03:00:00:000

3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

via: PR Newswire at 2019-06-11 03:00:00:000

3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

via: PR Newswire at 2019-06-11 03:00:00:000

3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-08-03 11.0 1.0 11.0
Data provided by IEX Cloud